ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new drug combo to stop aggressive breast Cancer's return
Disease control Recruiting nowThis large study is testing whether adding a CDK4/6 inhibitor drug to standard hormone therapy helps prevent breast cancer from coming back in high-risk patients. It involves about 1,900 women with a specific type of early-stage breast cancer (HR+/HER2+) who have already complete…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Sitting less during cancer care: can a phone app boost health?
Symptom relief Recruiting nowThis study is testing whether a digital support tool can help people with breast, prostate, or colorectal cancer sit less during their treatment. The goal is to see if reducing long periods of sitting improves their well-being, reduces side effects, and lowers future health risks…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Mälardalen University • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
Researchers track why breast cancer sometimes comes back after powerful drugs
Knowledge-focused Recruiting nowThis study aims to understand why some early-stage breast cancers return after patients finish treatment with specific drugs called CDK4/6 inhibitors. Researchers will follow 750 patients who have taken these drugs to see who relapses and analyze their medical details. The goal i…
Matched conditions: ADJUVANT THERAPY
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC